Mainz Biomed B.V. (MYNZ)

USD 3.14

(-0.32%)

Operating Income Summary of Mainz Biomed B.V.

  • Mainz Biomed B.V.'s latest annual operating income in 2023 was -26.64 Million USD , down -1.8% from previous year.
  • Mainz Biomed B.V.'s latest quarterly operating income in 2023 FY was -26.64 Million USD , down -1.8% from previous quarter.
  • Mainz Biomed B.V. reported an annual operating income of -26.17 Million USD in 2022, down -179.07% from previous year.
  • Mainz Biomed B.V. reported an annual operating income of -9.37 Million USD in 2021, down -2778.74% from previous year.
  • Mainz Biomed B.V. reported a quarterly operating income of -6.48 Million USD for 2023 Q1, up 23.26% from previous quarter.
  • Mainz Biomed B.V. reported a quarterly operating income of -26.64 Million USD for 2023 FY, down -1.8% from previous quarter.

Annual Operating Income Chart of Mainz Biomed B.V. (2023 - 2019)

Created with Highcharts 11.1.0YearsOperating Income20192019.520202020.520212021.520222022.52023-30000000 USD-25000000 USD-20000000 USD-15000000 USD-10000000 USD-5000000 USD0 USD

Historical Annual Operating Income of Mainz Biomed B.V. (2023 - 2019)

Year Operating Income Operating Income Growth
2023 -26.64 Million USD -1.8%
2022 -26.17 Million USD -179.07%
2021 -9.37 Million USD -2778.74%
2020 -325.81 Thousand USD 64.66%
2019 -921.9 Thousand USD 0.0%

Peer Operating Income Comparison of Mainz Biomed B.V.

Name Operating Income Operating Income Difference
Aclaris Therapeutics, Inc. -97.35 Million USD 72.632%
Applied DNA Sciences, Inc. -10.95 Million USD -143.257%
Aspira Women's Health Inc. -18.85 Million USD -41.336%
Biodesix, Inc. -41.34 Million USD 35.551%
BioNexus Gene Lab Corp. -2.59 Million USD -927.329%
bioAffinity Technologies, Inc. -7.97 Million USD -234.177%
bioAffinity Technologies, Inc. -7.97 Million USD -234.177%
Bionano Genomics, Inc. -215.24 Million USD 87.621%
CareDx, Inc -101.9 Million USD 73.852%
Check-Cap Ltd. -19.28 Million USD -38.148%
Castle Biosciences, Inc. -67.97 Million USD 60.803%
DarioHealth Corp. -56.18 Million USD 52.58%
Exact Sciences Corporation -215.01 Million USD 87.608%
Fulgent Genetics, Inc. -72.69 Million USD 63.347%
Guardant Health, Inc. -564.72 Million USD 95.282%
ICON Public Limited Company 956.15 Million USD 102.787%
IDEXX Laboratories, Inc. 1.09 Billion USD 102.429%
Illumina, Inc. -1.06 Billion USD 97.508%
Intelligent Bio Solutions Inc. -10.28 Million USD -159.11%
iSpecimen Inc. -11.16 Million USD -138.552%
Standard BioTools Inc. -76.6 Million USD 65.216%
MDxHealth SA -27.32 Million USD 2.497%
23andMe Holding Co. -321.35 Million USD 91.709%
Medpace Holdings, Inc. 336.82 Million USD 107.911%
Myriad Genetics, Inc. -123.7 Million USD 78.46%
ENDRA Life Sciences Inc. -10.52 Million USD -153.259%
NeoGenomics, Inc. -107.73 Million USD 75.269%
Neogen Corporation 58.66 Million USD 145.42%
Inotiv, Inc. -81.46 Million USD 67.291%
Natera, Inc. -446.24 Million USD 94.029%
OpGen, Inc. -15.68 Million USD -69.836%
OPKO Health, Inc. -157.02 Million USD 83.031%
Psychemedics Corporation -2.92 Million USD -812.177%
Prenetics Global Limited -52.51 Million USD 49.261%
Prenetics Global Limited -52.51 Million USD 49.261%
Precipio, Inc. -7.62 Million USD -249.668%
Personalis, Inc. -109.93 Million USD 75.763%
RadNet, Inc. 98.69 Million USD 126.996%
Sera Prognostics, Inc. -39.82 Million USD 33.089%
Sotera Health Company 276.69 Million USD 109.63%
Neuronetics, Inc. -30.55 Million USD 12.795%
Star Equity Holdings, Inc. -4.34 Million USD -513.085%
Star Equity Holdings, Inc. -4.34 Million USD -513.085%
Trinity Biotech plc -27.04 Million USD 1.48%
T2 Biosystems, Inc. -49.66 Million USD 46.35%
Twist Bioscience Corporation -220.83 Million USD 87.934%
Exagen Inc. -22.83 Million USD -16.673%